US Conference on Rare Diseases and Orphan Products - Special Challenges in Rare Diseases

October 22-24, 2012
Washington, DC

Special Challenges in Rare Diseases

• Learn how the government and private sector are addressing the special challenges faced by patients and companies in the new health care environment
• Meet individuals who face the same challenges that you do
• Gain a better understanding of how the FDA and NIH work and how they interact with the drug and device development processes
• Learn ways to de-risk your investments in orphan products and understand better the timelines for research and regulatory reviews

Featured Speakers Include
Keynote:

• John J. Castellani: President & CEO Pharmaceutical Research and Manufacturers of America (PhRMA)

The US Conference on Rare Diseases and Orphan Products is Going Mobile! Download the Mobile App Today. The US Conference on Rare Diseases and Orphan Products app is FREE and available for all registered attendees on Android, iPhone, iPad, and Mobile Web version. Download the app to access a wide range of Rare Diseases and Orphan Products information as well as the ability to:      • Create and Manage your Agenda and Appointments      • Receive News and Announcements      • Network with Fellow Attendees      • Receive Event Information in Real-time      • View a List of Exhibiting Companies Download from the Android Market | Download from the Apple Store | Download Mobile Web Version To download, go to your mobile device’s app store and search for DIA/NORD RARE DISEASES. Table Top Exhibits View Exhibiting Companies Eager to Meet with You. Maximize Your Learning in Washington, DC Register for the post-conference workshop,Clinical Trial Endpoints: Methods and Practice in Developing Measurements which has a special emphasis on rare diseases - and save $200 off your registration.* Contact Customer Service if you would like to attend this one-day workshop. Clinical Trial Endpoints: Methods and Practice in Developing Measurements October 25 | 8:30 AM – 5:00 PM *Discounts taken from your Clinical Trial Endpoints: Methods and Practice in Developing Measurements registration fee. Follow #DIARAREDISEASES on Twitter for real-time updates.

Meeting Program

 

Counterfeit Prescription Drugs - Partnership for Safe Medicines -> live on c-span

http://www.c-spanvideo.org/program/308446-1

Public Affairs Event
September 28, 2012

MAIN SPEAKERS:
Dr. Margaret Hamburg, Commissioner, U.S. Food & Drug Administration
John Castellani, President and Chief Executive Officer, Pharmaceutical Research and Manufacturers of America (PhRMA)
James Dinkins, Executive Associate Director, ICE s Homeland Security Investigations
Gerald Heddell, Director of Inspection, Enforcement and Standards, MHRA
Linda Marks, Senior Litigation Counsel, Department of Justice
Damon McCoy, Assistant Professor, George Mason University
Ralph G. Neas, President and Chief Executive Officer, Generic Pharmaceutical Association (GPhA)
John Roth, Director of the U.S. Food and Drug Administration Office of Criminal Investigations

#PhRMA12 Conversations: Dr. Tim Coté

PhRMA’s Annual Meeting is right around the corner. As you’ve seen in a previous post by our CEO John Castellani, this year’s meeting “is appropriately titled ‘Making Medicines do More,’ and its goal is to better tell the story of America’s biopharmaceutical research industry.” We are really looking forward to the discussions in the conference rooms and online.

I wanted to get started a little early, though, so I talked to a few people that represent the most important voices in health care – patients. In these interviews, we talked about the role of partnerships, how they would like to challenge the biopharmaceutical industry, and their goals for the future of health care. Their personal experiences made for some very compelling conversations.

http://www.phrma.org/catalyst/phrma12-conversations-dr-tim-cote